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893-2 Left Ventrlcular Ultrestructurel Lesions Are Independent 
Predictors for  10-Year Mortality After Aort ic Valve 
Replacement In Chronic Aortic Regurgitation: A Study 
With Percutaneous Endomyocerdlal  Left Ventricular 
Biopsy 
Katv Didier, Francois Schiele, Bemardette Kantelip, Yvette Bernard, Jean-Pierre L. 
Bassend, University Hospital Jean-Minjoz, Besancon, France. 
Aim: To assess the impact of preoperative histological changes on 10 year mortality after 
aortic valve replacement (AVR) in chronic aortic regurgitation. 
Methods: Percutaneaus left ventricular endomyocardist biopsy was obtained in 38 patients, 
before AVR. Mean fibrous diameter (MFD) and percent of interstitial tissue (%IT) were 
assessed by histomorphometry; ultrastructural lesions were semi-quantitatively measured 
by electronic microscopy with a three level scale (0 =minimal or none, 1= mild, 2=severs). 
Patients were followed over 10 years and predictors for death and for death + cardiac fail- 
ure were identified from clinical, echographic, angiogrephic and histological vadables. 
Results: Unlvadate and multivadate results are presented in the table. Among the histolog- 
ical variables, only the extent of cellular lesions were predictors of 10 year mortality. 
Conclusions: Older age and level of ultrastructural lesions, assessed by electronic micros- 
copy is an independent predictor for 10 year mortality after AVR in chronic aortic regurgita- 
tion. 
Variables Death Death(multivariate) Death+cardiac Death+cardiac 
(univariate) failure failure 
(univariate) (multivariate) 
Age (year/ p=0.0001 OR=1.0911;1.2] P---0.05 P=0.22 
multivariate) 
End-diastolio P=0.002 OR=0.97[0.95;0.99] p=0.16 P=0.18 
volume (/ml.m "1 
multivariate) 
Lesion=0 P=0.001 ORal P=0.02 ORal 
Leaion=l OR=3[0.4;25] ORal .6[0.4;9] 
Lesion=2 OR=3612;600] OR=1811.5;200] 
MDF P=0.92 NS P=0.68 NS 
%IT P=0.50 NS P=0.45 NS 
11:00 a.m. 
893-3 The Role of Matrix Metalloproteinasea in Human 
Cardiac Valve Diseases 
Olivier Fondard. Home Adle, Dominique Henin, Jean-Paul Couetfl, Ulrich Hvass, Alec 
Vahanian, Marie-Paule Jacob, INSERM U460, Paris, France. 
Background: Cardiac valve diseases are characterised by pathological remodeling of val- 
vular tissue but the cellular and molecular effectors involved in these processes are not 
well known. Hera we investigate the role of matrix metalioprcteinases (MMPs) in the differ- 
ent classes of valve diseases. 
Methods; Pathological valves ware collected during surgery, and the controls, non-cryo- 
preserved homogrefts, at a human tissue bank. Valves were classified according to their 
pathology and divided into 6 groups : aortic controls, aortic stenosis (AS), aortic regurgita- 
tion (AR), mitrel controls, mitrel stenosis and mitral regurgitation (MR). A total of 55 valves 
(35 aortic and 20 mitral) were studied histologically at the cellular and extrecellular matdx 
levels. The biochemical analyses (zymography, reverse zymography and westem blot) 
were performed on 29 tissue extracts and 52 tissue explant supematants. We measured 
the activity of MMP-2, -9, -3 and -7 in extracts and supematants and their inhibitors 
(TIMPs) TIMP-1 and -2 In extracts. 
Results: Histological study showed fibrotic, inflammatory and calcified lesions in AS and 
mitre/ stenosis, and dystrophic lesions in AR and MR. Zymography of supernatants 
showed that the MMP-2/proMMP-2 ratio was significantly increased (p<0,05) in AS com- 
pared with aortic controls. It was also increased in AR, mitral stenosis and MR. In extracts, 
the MMP-2/I"IMP-2 ratio was decreased (p<0,05) in both AS and AR compared with aortic 
controls. These results are in favour of extracallular matdx accumulation in aortic valvular 
disease. We cannot conclude for mitral valvular disease. The MMP-9 activity in extracts is 
increased in AS and MR, attesting the inflammatory state of these valves. Lastly, MMP-3 
and MMP-7 are present in the extracts but do not diffuse into the supematant. 
Concluston: Our study demonstrates the involvement of the MMP system in the extracel- 
lular matrix remodeling of both dystrophic and degenerative valve diseases. 
11:15 a.m. 
893-4 Role of Osteoprotegerin in the Pathogenesis of Calclf ic 
Aortic Stenoals 
Jens J. Kaden, Svetlana Bickelhaupt, Ralner Grobholz, Christian Vahl, Kad K. Haase, 
Cad E. Dempfle, Martin Borggrefa, University of Heidelberg, Mannheim, Germany. 
Background: Calcitic aortic stenosis is the main heart valve disease in eldedy patients. 
It is characterised by extensive calcification of the valve. Recent studies have shown that 
the process of calcification is actively regulated, and that bone matdx proteins are 
expressed in calcified valves. Ostecprotegerin (OPG), a novel soluble member of the 
tumor necrosis factor receptor superfamily, has been shown to regulate osteogenesis 
and to protect vascular tissue from calcification. The role of OPG in the pathogenesis of 
calcific aortic stenosis is not known. Methods: Human tricuspid aortic valves with (n=14) 
and without (n=5) calcific aortic stenosis were obtained at valve replacement or autopsy. 
Immunohistochemistry on cryosections was performed using a monocional antibody 
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against OPG. The number of immunostained calls, the total cell number, and the percent- 
age of positive cells were determined for each valve. To study the Iocalisation of immun- 
ostaining, the presence of calcification was determined for each field of view. All numbers 
are expressed as mean±standard eviation. Results: The percentage of cells positive 
for OPG was significantly lower in stenotic than in normal valves (3.6±6.1% vs 
19.6±14.7%, Mann-Whitney test, p=0.004). Fields of view with calcification (n=397) 
exhibited significantly less cells positive for OPG than fields of view without calcification 
(n=135) both in absolute cell number (26.3:P..23.3 vs cells 0±5.0 cells, t-teat p<0.0001) 
and as pementege of total cells (1.9±5.3% vs 5.6±12.7%, t-test p<0.0001). Conclusion: 
Our study demonstrates for the first time the presence of OPG in human aortic valves. 
Stenctic valves showed a significantly reduced expression of OPG. These results sug- 
gest that the OPG pathway is involved in the pathogenesis of calcific aortic stenosis and 
that OPG may protect valvular tissue from calcification. 
11:30 a.m. 
893-5 Aort ic Valve Calcium Measured by Electron Beam 
Computed Tomography: A Potential New Measure of 
Aortic Stenosis Severity 
David Shavalle, Matthew J. Budoff, NedUjka Buljubasic, J. Michael Cdley, Junichuro 
Takasu, SongShou Mac}, Xue-Qiao Zhao, Kevin O'Bdan, University of Washington, 
Seattle, Washington, Harbor-UCLA Research and Education Institute, Torrance, 
Califomia. 
Background: Aortic valve sclerosis affects 25% of patients over the age of 65 and may 
represent an eady stage in the development of aortic valve stenosis (AS). Calcification of 
the valve leaflets is a central component of the disease process, but is difficult o accu- 
rately quantify. Electron beam computed tomegraphy (EBT) is a noninvasive and accu- 
rate method for quantifying calcium. The purpose of this study was to compare EBT 
assessed aortic valve calcium (AVC) with echocardiegraphic and invasive measures of 
AS severity. Methods: The study population consisted of 53 patients who underwent 
EBT coronary scanning, echocardiography and/or left heart catheterization for the evalu- 
ation of aortic sclerosis or AS. Aortic sclerosis was defined as maximum aortic jet velocity 
(AV) by echocardiography of less than 2.0 m/s and no restriction to valve leaflet opening. 
Mild, moderate and severe AS were defined as maximum AV of 2 to 3, 3 to 4 and >4.0 m/ 
s, respectively and restriction to valve leaflet opening. The maximum transeortic gradient 
(Max AV gradient) was measured by left heart catheterization. Results: 29 patients had 
aortic sclerosis; 24 had varying degrees of AS. AVC by EBT was directly related to aortic 
jet velocity and Max AV gradient (Table). Conclusions: This study demonstrates that 
EBT measured AVC correlates with other measures of AS severity. EBT offers the ability 
to quantity AVC and therefore provides a new imaging modality to evaluate novel thera- 
pies to treat aortic valve disease. 
Aortic Jet Velocity (m/s) . <2.0 2.0-3.0 3.0-4.0 >4.0 p (trend) 
AVC Volume Score 87 242 848 1389 <0.001 
11:45 a.m. 
893-6 Increased Fibronectln Synthesis Is Stimulated by 
Autocr ine Factors Secreted by Fibroblaata From Aort ic 
Regurgltant Hearts 
Sharada L. Truter. Jennifer A. Lee, Themy F. Dumlao, Jr., Euegsuk Lee, Jeffrey S. Borer, 
Weft/Medica/Col/ege of Come//Universi~ New York, New York. 
Background: Myocardial fibrosis contributes to heart failure in chronic aortic regurgitation 
(AR). In experimental AR, we showed myocardial fibrous tissue is abnormally rich in 
fibronectin (FN). From recant data, cardiac fibroblast (CF) paracdne factors induce myo- 
cyte hypertrophy in hypertension. Thus, we sought CF-derived factors that promote CF 
FN expression in AR. Methods: CF were cultured from 3 nl NZW rabbits and 3 with surgi- 
cal AR (R fractions: >70%, 25%, 14%). Then, triplicate nI-CF cultures were grown for 24 
hrs in their own conditioned media (CM) or in CM from AR-CF cultures; AR-CF ware sim- 
ilarly treated. CF FN synthesis was measured by westam blot and gelatin sepharose 
affinity chromatography (GSAC); northern analyses were done. CM were filtered through 
30, 50 and 100kD sieve columns and assays repeated. Results: FN was upregulated in 
AR vs nl [AR:nI= 2.7:l(Westarn, p=.02), 1.4:I(GSAC, ns), 2.2:1(Northern, p=.045)}. 
Recuituring AR-CF in CM from nI-CF cultures had little effect on FN synthesis or gena 
axprossion(ns); in contrast, reculturing nI-CF in CM from AR-CF caused FN upregulation 
by the nl CF; upregulation of FN synthesis and gene expression by nI-CF racultured in 
AR-CM were as follows (all values=av of triplicate assays): (Sea Table) 
Autocdne activity was seen in 100kD filtrate but less at 50kD and 30kD. Conclusion: In 
chronic AR, CF releases autocrine products that stimulate FN synthesis, providing poten- 
tial therapeutic tablets for minimizing fibrosis contributin~l toheart failure. 
nI-CF in CM from >70% AR-CF:nI-CF in CM from nI-CF 
Western 1.9:1 
GSAC 1.2:1 
Northern 2.4:1 
nI-CF in CM from 25% AR-CF:nI-CF in CM from nI-CF 
Western 2.1:1 
GSAC 1.7:1 
Northern 1.5:1 
nI-CF in CM from 14% AR-CF:nI-CF in CM from nI-CF 
Western 1.2:1 
GSAC 1.1:1 
Northern 1.4:1 
